Showing 36,121 - 36,140 results of 224,509 for search '(( a ((((laser decrease) OR (a decrease))) OR (linear decrease)) ) OR ( a large decrease ))', query time: 1.48s Refine Results
  1. 36121

    Image_4_Is there a causal association between gestational diabetes mellitus and immune mediators? A bidirectional Mendelian randomization analysis.tif by Zhangxin Ji (18408177)

    Published 2024
    “…The maternal physiological immune profile is essential for a positive pregnancy outcome. However, the causal relationship between GDM and immunophenotypes is not fully defined.…”
  2. 36122

    Table_3_Is there a causal association between gestational diabetes mellitus and immune mediators? A bidirectional Mendelian randomization analysis.xlsx by Zhangxin Ji (18408177)

    Published 2024
    “…The maternal physiological immune profile is essential for a positive pregnancy outcome. However, the causal relationship between GDM and immunophenotypes is not fully defined.…”
  3. 36123

    Table_2_Is there a causal association between gestational diabetes mellitus and immune mediators? A bidirectional Mendelian randomization analysis.xlsx by Zhangxin Ji (18408177)

    Published 2024
    “…The maternal physiological immune profile is essential for a positive pregnancy outcome. However, the causal relationship between GDM and immunophenotypes is not fully defined.…”
  4. 36124

    Primary peritoneal drainage in neonates with necrotizing enterocolitis associated with congenital heart disease: a single experience in a Brazilian tertiary center by W.C. Canesin (12728322)

    Published 2022
    “…We concluded that performing primary peritoneal drainage in neonates with or without CHD did not improve the number of days of life, did not decrease the risk of death, and was associated with a higher mortality in newborns with NEC and clinical instability.…”
  5. 36125

    Image_1_Risk of Venous Thromboembolism in Transgender People Undergoing Hormone Feminizing Therapy: A Prevalence Meta-Analysis and Meta-Regression Study.tif by Maria Totaro (11665708)

    Published 2021
    “…The pooled prevalence of VTE was 2% (95%CI:1-3%), with a large heterogeneity (I<sup>2 </sup>= 89.18%, P<0.0001). …”
  6. 36126

    Image_1_Risk of Venous Thromboembolism in Transgender People Undergoing Hormone Feminizing Therapy: A Prevalence Meta-Analysis and Meta-Regression Study.tif by Maria Totaro (11665708)

    Published 2021
    “…The pooled prevalence of VTE was 2% (95%CI:1-3%), with a large heterogeneity (I<sup>2 </sup>= 89.18%, P<0.0001). …”
  7. 36127

    Table_2_Risk of Venous Thromboembolism in Transgender People Undergoing Hormone Feminizing Therapy: A Prevalence Meta-Analysis and Meta-Regression Study.docx by Maria Totaro (11665708)

    Published 2021
    “…The pooled prevalence of VTE was 2% (95%CI:1-3%), with a large heterogeneity (I<sup>2 </sup>= 89.18%, P<0.0001). …”
  8. 36128

    Table_3_Risk of Venous Thromboembolism in Transgender People Undergoing Hormone Feminizing Therapy: A Prevalence Meta-Analysis and Meta-Regression Study.docx by Maria Totaro (11665708)

    Published 2021
    “…The pooled prevalence of VTE was 2% (95%CI:1-3%), with a large heterogeneity (I<sup>2 </sup>= 89.18%, P<0.0001). …”
  9. 36129

    Table_3_Risk of Venous Thromboembolism in Transgender People Undergoing Hormone Feminizing Therapy: A Prevalence Meta-Analysis and Meta-Regression Study.docx by Maria Totaro (11665708)

    Published 2021
    “…The pooled prevalence of VTE was 2% (95%CI:1-3%), with a large heterogeneity (I<sup>2 </sup>= 89.18%, P<0.0001). …”
  10. 36130

    Table_2_Risk of Venous Thromboembolism in Transgender People Undergoing Hormone Feminizing Therapy: A Prevalence Meta-Analysis and Meta-Regression Study.docx by Maria Totaro (11665708)

    Published 2021
    “…The pooled prevalence of VTE was 2% (95%CI:1-3%), with a large heterogeneity (I<sup>2 </sup>= 89.18%, P<0.0001). …”
  11. 36131

    Table_1_Risk of Venous Thromboembolism in Transgender People Undergoing Hormone Feminizing Therapy: A Prevalence Meta-Analysis and Meta-Regression Study.doc by Maria Totaro (11665708)

    Published 2021
    “…The pooled prevalence of VTE was 2% (95%CI:1-3%), with a large heterogeneity (I<sup>2 </sup>= 89.18%, P<0.0001). …”
  12. 36132

    Table_1_Risk of Venous Thromboembolism in Transgender People Undergoing Hormone Feminizing Therapy: A Prevalence Meta-Analysis and Meta-Regression Study.doc by Maria Totaro (11665708)

    Published 2021
    “…The pooled prevalence of VTE was 2% (95%CI:1-3%), with a large heterogeneity (I<sup>2 </sup>= 89.18%, P<0.0001). …”
  13. 36133
  14. 36134
  15. 36135
  16. 36136
  17. 36137

    DataSheet_1_Laparoscopy for the Treatment of Congenital Hernia: Use of Surgical Meshes and Mesenchymal Stem Cells in a Clinically Relevant Animal Model.docx by Federica Marinaro (5131016)

    Published 2020
    “…A significant decrease in the gene expression of VEGF and a significant increase in TNF expression were determined in the cell group 1 month after implantation compared with gene expressions in the control group (p < 0.05). …”
  18. 36138

    Metabolism of Phosphatidylinositol 4-Kinase IIIα-Dependent PI4P Is Subverted by HCV and Is Targeted by a 4-Anilino Quinazoline with Antiviral Activity by Annalisa Bianco (178719)

    Published 2012
    “…Accordingly, we observed a gradual decrease of PI4P in the plasma membrane upon incubation with AL-9, indicating that this agent inhibits PI4KIIIα also in living cells. …”
  19. 36139
  20. 36140